• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Therapy related acute non-lymphocytic leukemia: report of 4 cases.

作者信息

Atichartakarn V, Punyammalee B, Nitiyanant P

出版信息

Southeast Asian J Trop Med Public Health. 1985 Sep;16(3):421-30.

PMID:4095607
Abstract

Four cases of acute myelodysplastic-non-lymphocytic leukemia secondary to cytotoxic agents were reported. Primary diseases were breast cancer (1 patient), ovarian cancer (2 patients) and multiple myeloma (1 patient). All except one (with multiple myeloma) were in clinical remission of their primary diseases. Common cytotoxic agent used was melphalan. Median total drug dose and median latent period from diagnosis of primary diseases were 1299 mg and 63 months respectively. None with the exception of one received specific treatment. All died except one who is in a very poor condition. Survival from the diagnosis of hematologic diseases ranged from 3-9 months. Clinical features, cytogenetic findings, pathogenetic mechanism and risk of the disease were briefly discussed.

摘要

相似文献

1
Therapy related acute non-lymphocytic leukemia: report of 4 cases.
Southeast Asian J Trop Med Public Health. 1985 Sep;16(3):421-30.
2
Risk of leukemia after chemotherapy and radiation treatment for breast cancer.乳腺癌化疗和放疗后患白血病的风险。
N Engl J Med. 1992 Jun 25;326(26):1745-51. doi: 10.1056/NEJM199206253262605.
3
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.以米托蒽醌为基础的大剂量化疗治疗原发性乳腺癌患者后发生的继发性急性白血病。
Bone Marrow Transplant. 2003 Dec;32(12):1153-7. doi: 10.1038/sj.bmt.1704291.
4
Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.盆腔放疗与继发性白血病和多发性骨髓瘤风险。
Cancer. 2010 May 15;116(10):2486-92. doi: 10.1002/cncr.25067.
5
[Acute leukemia and breast cancer : apropos of 12 cases observed in the Department of Oncology at the Henri Mondor Hospital].
Bull Cancer. 1983;70(5):389-93.
6
Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.美法仑和泼尼松联合长春新碱、卡莫司汀、美法仑、环磷酰胺及泼尼松治疗多发性骨髓瘤的比较:东部肿瘤协作组E2479研究结果
Cancer. 1997 Apr 15;79(8):1561-7.
7
[Four cases of therapy-related leukemia in multiple myeloma].[多发性骨髓瘤中4例治疗相关白血病]
Gan To Kagaku Ryoho. 2007 Jan;34(1):121-4.
8
[Multiple myeloma and acute leukemia. Simultaneous evolution of plasmacyte and myelomonocytic clones].
Sem Hop. 1978;54(25-28):809-13.
9
Leukemia incidence following primary breast carcinoma treatment.原发性乳腺癌治疗后的白血病发病率。
Cancer. 2004 Oct 1;101(7):1529-36. doi: 10.1002/cncr.20475.
10
Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.自体干细胞移植后乳腺癌女性的染色体异常并不常见,且可能无法预测治疗相关白血病或骨髓增生异常综合征的发生。
Bone Marrow Transplant. 2000 Jun;25(11):1203-8. doi: 10.1038/sj.bmt.1702416.

引用本文的文献

1
Estrogen Downregulates miR-21 Expression and Induces Inflammatory Infiltration of Macrophages in Polymyositis: Role of CXCL10.雌激素下调miR-21表达并诱导多发性肌炎中巨噬细胞的炎性浸润:CXCL10的作用
Mol Neurobiol. 2017 Apr;54(3):1631-1641. doi: 10.1007/s12035-016-9769-6. Epub 2016 Feb 12.